A detailed history of Cherry Tree Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cherry Tree Wealth Management, LLC holds 334 shares of AZN stock, worth $21,806. This represents 0.01% of its overall portfolio holdings.

Number of Shares
334
Previous 334 -0.0%
Holding current value
$21,806
Previous $26 Million 0.1%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$66.81 - $80.83 $3,407 - $4,122
-51 Reduced 13.25%
334 $26 Million
Q1 2024

May 01, 2024

BUY
$61.03 - $69.57 $3,112 - $3,548
51 Added 15.27%
385 $26.1 Million
Q2 2023

Aug 09, 2023

BUY
$69.91 - $75.81 $23,349 - $25,320
334 New
334 $23.9 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $202B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cherry Tree Wealth Management, LLC Portfolio

Follow Cherry Tree Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cherry Tree Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cherry Tree Wealth Management, LLC with notifications on news.